AAilin
Ailin is a Madrid-based healthtech startup offering at-home diagnostic testing: users order self-sampling kits for 30+ blood and biomarker tests (preventive, hormonal, digestive, sexual and metabolic health), which are analyzed by accredited labs (including Clínica Universidad de Navarra) with medical interpretation delivered within 24-72 hours. Founded in 2021/2022 by Isabel Caruana, it holds CE marking and has raised a Seed round backed by Decelera Ventures, suda.partners, PharmStars and public support (CDTI Neotec).
SectorsHealthtech, Diagnostics, Digital Health, Preventive Health
Start-up MapHealthtech & Bio › Consumer & telehealth services
Founders
I
Isabel Caruana
Founder & CEO
Global models 5
LLetsGetChecked
Ireland · www.letsgetchecked.com ↗
At-home lab testing kits with clinician-reviewed results and telehealth follow-up, the closest large-scale global comparable to Ailin's model.
$385MComparable
EEverlywell
United States · www.everlywell.com ↗
Direct-to-consumer at-home biomarker and diagnostic test kits with lab analysis and digital results, mirroring Ailin's self-sampling model.
$308MComparable
FFunction Health
United States · www.functionhealth.com ↗
Subscription-based comprehensive biomarker testing with physician-reviewed results, same preventive/personalized diagnostics model as Ailin.
$253MComparable
SSuperpower
United States · www.superpower.com ↗
At-home and lab biomarker panels paired with AI-driven personalized health recommendations, akin to Ailin's preventive testing approach.
$40MComparable
TThriva
United Kingdom · thriva.co ↗
Finger-prick at-home blood testing kits with app-based results and clinician support, a smaller-scale European analogue to Ailin.
$15MComparable
In the same niche 60 others
See all in the Start-ups Map →
Notes: Most funded first
Investors 4
Open as list →
Funding rounds 1
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2024-02-20 | Seed (estimated) | €1.5M |
Lead not disclosed
+2 more
|
News
No coverage on record yet.